OptimizeRx Stock (NASDAQ:OPRX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$5.08

52W Range

$4.57 - $22.25

50D Avg

$5.91

200D Avg

$11.83

Market Cap

$99.08M

Avg Vol (3M)

$485.73K

Beta

1.10

Div Yield

-

OPRX Company Profile


OptimizeRx Corporation is a digital health technology firm delivering a broad spectrum of solutions to life sciences organizations, healthcare providers, and patients. Its core offerings encompass financial messaging and a virtual patient support hub, enabling healthcare providers to seamlessly access sample vouchers, co-pay assistance, and other patient support resources directly within their electronic medical records (EMR) or e-prescribing platforms. The company also facilitates brand awareness and therapeutic communication through various messaging services, including targeted ads and unbranded educational content. Additionally, OptimizeRx consults with pharmaceutical manufacturers, guiding them in devising and executing effective eRx media strategies, which involves drug file integration, sales force education, and comprehensive strategy development for product promotion. It operates a cloud-based Mobile Health Messenger platform, offering interactive health messaging to bolster medication adherence and improve care coordination. Furthermore, a HIPAA-compliant automated mobile messaging platform empowers pharmaceutical companies and associated entities to directly connect with patients, fostering better regimen compliance. Patient-centric programs provide essential treatment and affordability details, alongside lifestyle and condition trackers, internet device integration, and tools for forms and surveys. For healthcare professionals, the company offers an evidence-based physician engagement solution that leverages real-world data. This tool helps identify patients suitable for particular therapies, raises awareness of patient access routes, and detects early signs of non-adherence within patient groups. Another key offering is a therapy initiation workflow designed to expedite patient access to treatments, especially those requiring extensive medical documentation from healthcare providers before pharmacists can dispense prescribed medications. Established in 2006, OptimizeRx is headquartered in Rochester, Michigan.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

128

IPO Date

Nov 28, 2007

Website

OPRX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25
Other Revenue$215.00K

Fiscal year ends in Dec 25 | Currency in USD

OPRX Financial Summary


Dec 25Dec 24Dec 23
Revenue$109.43M$92.13M$71.52M
Operating Income$12.06M$-13.71M$-26.40M
Net Income$5.13M$-20.11M$-17.57M
EBITDA$16.39M$-8.90M$-21.31M
Basic EPS$0.28$-1.10$-1.03
Diluted EPS$0.27$-1.10$-1.03

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 12, 26 | 12:00 AM
Q4 25Mar 05, 26 | 4:30 PM
Q3 25Nov 07, 25 | 4:30 PM

Peer Comparison


TickerCompany
SLPSimulations Plus, Inc.
NAKANakamoto Inc.
SMLRSemler Scientific, Inc.
RXSTRxSight, Inc.
DRUGBright Minds Biosciences Inc.
NRCNational Research Corporation
TBRGTruBridge, Inc.
SPOKSpok Holdings, Inc.
SOPHSOPHiA GENETICS S.A.
DHDefinitive Healthcare Corp.